IRF4 and Miyoshi myopathy: The synergistic Sp1 reduction markedly suppressed Sp1-driven prosurvival factors, interferon regulatory factor 4 (IRF4) and cMyc, while potentiating HDAC inhibition in part through HDAC1 reduction in MM cells.